Metabolic syndrome in menopause and associated factors: a meta-analysis

References

• Shifren JL, Gass ML. NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women. Menopause 2014;21:1038–62
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A. IMS Writing Group. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar
• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595–607
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–5
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356–9
   PubMed Web of Science ®Google Scholar
• Beltrán-Sánchez H, Harhay MO, Harhay MM, et al. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol 2013;62:697–703
   PubMed Web of Science ®Google Scholar
• Stefanska A, Bergmann K, Sypniewska G. Metabolic syndrome and menopause: pathophysiology, clinical and diagnostic significance. Adv Clin Chem 2015;72:1–75
   PubMed Web of Science ®Google Scholar
• Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427–36
   PubMed Web of Science ®Google Scholar
• Pucci G, Alcidi R, Tap L, et al. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: a review of the literature. Pharmacol Res 2017;120:34–42
   PubMed Web of Science ®Google Scholar
• Shah D. The annual conference of the British menopause society: June 2010. J Midlife Health 2010;1:48–50
   PubMedGoogle Scholar
• Farahmand M, Ramezani Tehrani F, Bahri Khomami M, et al. Surgical menopause versus natural menopause and cardio-metabolic disturbances: a 12-year population-based cohort study. J Endocrinol Invest 2015;38:761–7
   PubMed Web of Science ®Google Scholar
• Michelsen TM, Pripp AH, Tonstad S, et al. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. Eur J Cancer 2009;45:82–9
   PubMed Web of Science ®Google Scholar
• Kilic S, Yilmaz N, Erdogan G, et al. Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women. Climacteric 2010;13:55–62
   PubMed Web of Science ®Google Scholar
• Farahmand M, Ramezani Tehrani F, Simbar M, Mehrabi Y, Khalili D, Azizi F. Does metabolic syndrome or its components differ in naturally and surgically menopausal women? Climacteric 2014;17:348–55
   PubMed Web of Science ®Google Scholar
• Ozdemir S, Celik C, Görkemli H, et al. Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome. Int J Gynaecol Obstet 2009;106:57–61
   PubMed Web of Science ®Google Scholar
• Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005;48:1684–99
   PubMed Web of Science ®Google Scholar
• Coyoy A, Guerra-Araiza C, Camacho-Arroyo I. Metabolism regulation by estrogens and their receptors in the central nervous system before and after menopause. Horm Metab Res 2016;48:489–96
   PubMed Web of Science ®Google Scholar
• Morselli E, Santos RS, Criollo A, et al. The effects of oestrogens and their receptors on cardiometabolic health. Nat Rev Endocrinol 2017;13:352–64
   PubMed Web of Science ®Google Scholar
• Kim C, Halter JB. Endogenous sex hormones, metabolic syndrome, and diabetes in men and women. Curr Cardiol Rep 2014;16:467
   PubMed Web of Science ®Google Scholar
• Nii S, Shinohara K, Matsushita H, et al. Hepatic effects of estrogen on plasma distribution of small dense low-density lipoprotein and free radical production in postmenopausal women. J Atheroscler Thromb 2016;23:810–18
   PubMed Web of Science ®Google Scholar
• Christodoulakos GE, Lambrinoudaki IV, Economou EV, et al. Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma. J Cardiovasc Pharmacol 2006;47:542–8
   PubMed Web of Science ®Google Scholar
• Cortellaro M, Nencioni T, Boschetti C, et al. Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment. Eur J Clin Pharmacol 1991;41:555–9
   PubMed Web of Science ®Google Scholar
• de Kraker AT, Kenemans P, Smolders RG, et al. The effects of 17 beta-oestradiol plus dydrogesterone compared with conjugated equine oestrogens plus medroxyprogesterone acetate on lipids, apolipoproteins and lipoprotein(a). Maturitas 2004;49:253–63
   PubMed Web of Science ®Google Scholar
• Ichikawa J, Sumino H, Ichikawa S, et al. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women. Am J Hypertens 2006;19:744–9
   PubMed Web of Science ®Google Scholar
• Rabbani LE, Seminario NA, Sciacca RR, et al. Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women. J Am Coll Cardiol 2002;40:1991–9
   PubMed Web of Science ®Google Scholar
• Sendag F, Karadadas N, Ozsener S, et al. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women. Arch Gynecol Obstet 2002;266:38–43
   PubMedGoogle Scholar
• Sumino H, Ichikawa S, Kasama S, et al. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women. Atherosclerosis 2006;189:436–42
   PubMed Web of Science ®Google Scholar
• Farr JN, Khosla S, Miyabara Y, et al. Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women. J Clin Endocrinol Metab 2013;98:E249–57
   PubMed Web of Science ®Google Scholar
• Wroolie TE, Kenna HA, Williams KE, et al. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens. Am J Geriatr Psychiatry 2011;19:792–802
   PubMed Web of Science ®Google Scholar
• The Cochrane Collaboration. Cochrane Handbook for Systematic reviews of interventions, Version 5.1.0. Available from: http://handbook-5-1.cochrane.org/ [last accessed 2011]
   Google Scholar
• Bednarek-Tupikowska G, Filus A, Kuliczkowska-Płaksej J, et al. Serum leptin concentrations in pre- and postmenopausal women on sex hormone therapy. Gynecol Endocrinol 2006;22:207–12
   PubMed Web of Science ®Google Scholar
• Behall KM, Scholfield DJ, Hallfrisch J. Whole-grain diets reduce blood pressure in mildly hypercholesterolemic men and women. J Am Diet Assoc 2006;106:1445–9
   PubMed Web of Science ®Google Scholar
• Bessesen DH, Cox-York KA, Hernandez TL, et al. Postprandial triglycerides and adipose tissue storage of dietary fatty acids: impact of menopause and estradiol. Obesity (Silver Spring) 2015;23:145–53
   PubMed Web of Science ®Google Scholar
• Blumenthal JA, Matthews K, Fredrikson M, et al. Effects of exercise training on cardiovascular function and plasma lipid, lipoprotein, and apolipoprotein concentrations in premenopausal and postmenopausal women. Arterioscler Thromb 1991;11:912–17
   PubMed Web of Science ®Google Scholar
• Campbell MJ, Woodside JV, Honour JW, et al. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study. Eur J Clin Nutr 2004;58:173–9
   PubMed Web of Science ®Google Scholar
• Dasgupta S, Salman M, Lokesh S, et al. Menopause versus aging: the predictor of obesity and metabolic aberrations among menopausal women of Karnataka, South India. J Midlife Health 2012;3:24–30
   PubMedGoogle Scholar
• Farag NH, Whitsett TL, McKey BS, et al. Caffeine and blood pressure response: sex, age, and hormonal status. J Womens Health (Larchmt) 2010;19:1171–6
   PubMed Web of Science ®Google Scholar
• Grandjean PW, Crouse SF, O'Brien BC, et al. The effects of menopausal status and exercise training on serum lipids and the activities of intravascular enzymes related to lipid transport. Metabolism 1998;47:377–83
   PubMed Web of Science ®Google Scholar
• Joo JK, Hong GP, Han SE, et al. The association between serum uric acid level and incidence of metabolic syndrome according to menopausal status in Korean women. J Menopausal Med 2014;20:126–32
   PubMedGoogle Scholar
• Kruger MC, Chan YM, Kuhn-Sherlock B, et al. Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women. Eur J Nutr 2016;55:1911–21
   PubMed Web of Science ®Google Scholar
• Lindheim SR, Legro RS, Bernstein L, et al. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol 1992;167:1831–6
   PubMed Web of Science ®Google Scholar
• Lindheim SR, Buchanan TA, Duffy DM, et al. Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig 1994;1:150–4
   PubMedGoogle Scholar
• Manabe E, Aoyagi K, Tachibana H, et al. Relationship of intra-abdominal adiposity and peripheral fat distribution to lipid metabolism in an island population in western Japan: gender differences and effect of menopause. Tohoku J Exp Med 1999;188:189–202
   PubMed Web of Science ®Google Scholar
• Menzel J, Di Giuseppe R, Biemann R, et al. Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. J Endocrinol Invest 2016;39:1347–55
   PubMed Web of Science ®Google Scholar
• Moreau KL, Deane KD, Meditz AL, et al. Tumor necrosis factor-α inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women. Atherosclerosis 2013;230:390–6
   PubMed Web of Science ®Google Scholar
• Muti P, Quattrin T, Grant BJ, et al. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002;11:1361–8
   PubMed Web of Science ®Google Scholar
• Paoletti AM, Pilloni M, Orrù M, et al. Efficacy and safety of oral and transdermal hormonal replacement treatment containing levonorgestrel. Maturitas 2002;42:137–47
   PubMed Web of Science ®Google Scholar
• Perregaux D, Chaudhuri A, Mohanty P, et al. Effect of gender differences and estrogen replacement therapy on vascular reactivity. Metabolism 1999;48:227–32
   PubMed Web of Science ®Google Scholar
• Prelevic GM, Beljic T. The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal women. Maturitas 1994;20:37–44
   PubMed Web of Science ®Google Scholar
• Sanada M, Nakagawa H, Kodama I, et al. The effect of hormone replacement therapy on metabolism of lipoprotein remnants in postmenopausal women. Maturitas 2000;34:75–82
   PubMed Web of Science ®Google Scholar
• Schaefer EJ, Lamon-Fava S, Cohn SD, et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 1994;35:779–92
   PubMed Web of Science ®Google Scholar
• Stoney CM, West SG, Hughes JW, et al. Acute psychological stress reduces plasma triglyceride clearance. Psychophysiology 2002;39:80–5
   PubMed Web of Science ®Google Scholar
• Suliga E, Kozieł D, Cieśla E, et al. Factors associated with adiposity, lipid profile disorders and the metabolic syndrome occurrence in premenopausal and postmenopausal women. PLoS One 2016;11:e0154511
   PubMed Web of Science ®Google Scholar
• Ushiroyama T, Nosaka S, Ueki M. Short-term effects of low-dose atorvastatin on inflammatory status and lipid profiles in perimenopausal hypercholesterolemic, hypertriglyceridemic women. Int J Cardiol 2006;113:66–75
   PubMed Web of Science ®Google Scholar
• van Beek AP, de Ruijter-Heijstek FC, Erkelens DW, et al. Menopause is associated with reduced protection from postprandial lipemia. Arterioscler Thromb Vasc Biol 1999;19:2737–41
   PubMed Web of Science ®Google Scholar
• Vega-López S, Vidal-Quintanar RL, Fernandez ML. Sex and hormonal status influence plasma lipid responses to psyllium. Am J Clin Nutr 2001;74:435–41
   PubMed Web of Science ®Google Scholar
• Wingrove CS, Garr E, Pickar JH, et al. Effects of equine oestrogens on markers of vasoactive function in human coronary artery endothelial cells. Mol Cell Endocrinol 1999;150:33–7
   PubMed Web of Science ®Google Scholar
• Yamatani H, Takahashi K, Yoshida T, et al. Differences in the fatty acid metabolism of visceral adipose tissue in postmenopausal women. Menopause 2014;21:170–6
   PubMed Web of Science ®Google Scholar
• Yoon BI, Han KD, Lee KW, et al. Insulin resistance is associated with prevalence of physician-diagnosed urinary incontinence in postmenopausal non-diabetic adult women: data from the Fourth Korea National Health and Nutrition Examination Survey. PLoS One 2015;10:e0141720
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhuang Y, Qiang H, et al. Relationship between endogenous estrogen concentrations and serum cholesteryl ester transfer protein concentrations in Chinese women. Clin Chim Acta 2001;314:77–83
   PubMed Web of Science ®Google Scholar
• Jeenduang N, Trongsakul R, Inhongsa P, et al. The prevalence of metabolic syndrome in premenopausal and postmenopausal women in Southern Thailand. Gynecol Endocrinol 2014;30:573–6
   PubMed Web of Science ®Google Scholar
• Dørum A, Tonstad S, Liavaag AH, et al. Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecol Oncol 2008;109:377–83
   PubMed Web of Science ®Google Scholar
• Zuo H, Shi Z, Hu X, et al. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism 2009;58:1102–8
   PubMed Web of Science ®Google Scholar
• Ben Ali S, Belfki-Benali H, Aounallah-Skhiri H, et al. Menopause and metabolic syndrome in tunisian women. Biomed Res Int 2014;2014:457131
   PubMed Web of Science ®Google Scholar
• Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas 2010;65:262–6
   PubMed Web of Science ®Google Scholar
• Sharma S, Aggarwal N, Joshi B, et al. Prevalence of metabolic syndrome in pre- and post-menopausal women: a prospective study from apex institute of North India. J Midlife Health 2016;7:169–74
   PubMedGoogle Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 1998;15:539–53
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–97
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome–a new worldwide definition. Lancet 2005;366:1059–62
   PubMed Web of Science ®Google Scholar
• Rusinek H, Convit A. Obesity: cerebral damage in obesity-associated metabolic syndrome. Nat Rev Endocrinol 2014;10:642–4
   PubMed Web of Science ®Google Scholar
• Donato GB, Fuchs SC, Oppermann K, et al. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause 2006;13:280–5
   PubMed Web of Science ®Google Scholar
• Kwaśniewska M, Pikala M, Kaczmarczyk-Chałas K, et al. Smoking status, the menopausal transition, and metabolic syndrome in women. Menopause 2012;19:194–200
   PubMed Web of Science ®Google Scholar
• St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care 2004;27:2222–8
   PubMed Web of Science ®Google Scholar
• McQueen MJ, Hawken S, Wang X, et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008;372:224–33
   PubMed Web of Science ®Google Scholar
• Stokes J, 3rd, Kannel WB, Wolf PA, et al. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987;75:V65–73
   PubMed Web of Science ®Google Scholar
• Taddei S. Blood pressure through aging and menopause. Climacteric 2009;12(Suppl 1):36–40
   PubMed Web of Science ®Google Scholar
• Staessen J, Bulpitt CJ, Fagard R, et al. The influence of menopause on blood pressure. J Hum Hypertens 1989;3:427–33
   PubMed Web of Science ®Google Scholar
• Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension: an age-old debate. Hypertension 2008;51:952–9
   PubMed Web of Science ®Google Scholar
• Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006;47:1093–100
   PubMed Web of Science ®Google Scholar
• Ford ES, Li C, Sattar N. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 2008;31:1898–904
   PubMed Web of Science ®Google Scholar
• Meigs JB, Rutter MK, Sullivan LM, et al. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007;30:1219–25
   PubMed Web of Science ®Google Scholar
• Gurka MJ, Vishnu A, Santen RJ, et al. Progression of metabolic syndrome severity during the menopausal transition. J Am Heart Assoc 2016;5:e003609
   PubMed Web of Science ®Google Scholar
• Zivkovic TB, Vuksanovic M, Jelic MA, et al. Obesity and metabolic syndrome during the menopause transition in Serbian women. Climacteric 2011;14:643–8
   PubMed Web of Science ®Google Scholar
• Li L, Wu J, Pu D, et al. Factors associated with the age of natural menopause and menopausal symptoms in Chinese women. Maturitas 2012;73:354–60
   PubMed Web of Science ®Google Scholar
• Hendrix SL. Bilateral oophorectomy and premature menopause. Am J Med 2005;118(Suppl 12B):131–5
   PubMed Web of Science ®Google Scholar
• Shoupe D, Parker WH, Broder MS, et al. Elective oophorectomy for benign gynecological disorders. Menopause 2007;14:580–5
   PubMed Web of Science ®Google Scholar
• Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, et al. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000;85:645–51
   PubMed Web of Science ®Google Scholar
• Howard BV, Kuller L, Langer R, et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women’s Health Initiative Observational Study. Circulation 2005;111:1462–70
   PubMed Web of Science ®Google Scholar
• Lobo RA. Surgical menopause and cardiovascular risks. Menopause 2007;14:562–6
   PubMed Web of Science ®Google Scholar
• Parker WH, Broder MS, Liu Z, et al. Ovarian conservation at the time of hysterectomy for benign disease. Clin Obstet Gynecol 2007;50:354–61
   PubMed Web of Science ®Google Scholar
• Bonithon-Kopp C, Scarabin PY, Darne B, et al. Menopause-related changes in lipoproteins and some other cardiovascular risk factors. Int J Epidemiol 1990;19:42–8
   PubMed Web of Science ®Google Scholar
• Tuna V, Alkiş I, Safiye AS, Imamoglu N, Bayram N, Ali Ismet T. Variations in blood lipid profile, thrombotic system, arterial elasticity and psychosexual parameters in the cases of surgical and natural menopause. Aust NZ J Obstet Gynaecol 2010;50:194–9
   PubMed Web of Science ®Google Scholar
• Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015;19:CD002229
   Google Scholar
• Saltevo J, Puolakka J, Ylikorkala O. Plasma endothelin in postmenopausal women with type 2 diabetes mellitus and metabolic syndrome: a comparison of oral combined and transdermal oestrogen-only replacement therapy. Diabetes Obes Metab 2000;2:293–8
   PubMed Web of Science ®Google Scholar
• Hsia J, Bittner V, Tripputi M, et al. Metabolic syndrome and coronary angiographic disease progression: the Women’s Angiographic Vitamin & Estrogen trial. Am Heart J 2003;146:439–45
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Walsh JM, Ormiston TM, et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006;8:538–54
   PubMed Web of Science ®Google Scholar
• Mirkin S, Amadio JM, Bernick BA, et al. 17β-Estradiol and natural progesterone for menopausal hormone therapy: REPLENISH phase 3 study design of a combination capsule and evidence review. Maturitas 2015;81:28–35
   PubMed Web of Science ®Google Scholar